CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-10-04 | TOBIN JAMES R Director | Other disposition · Non-qualified stock option (right to buy) | −2,500 | 170,000 | ||
| 2010-10-04 | TOBIN JAMES R Director | Other disposition · Non-qualified stock option (right to buy) | −5,000 | 175,000 | ||
| 2010-10-04 | TOBIN JAMES R Director | Other disposition · Non-qualified stock option (right to buy) | −5,000 | 180,000 | ||
| 2010-10-04 | TOBIN JAMES R Director | Other disposition · Non-qualified stock option (right to buy) | −7,500 | 187,500 | ||
| 2010-10-04 | TOBIN JAMES R Director | Other disposition · Non-qualified stock option (right to buy) | −7,500 | $1.39 | $10K | 195,000 |
| 2010-10-04 | TOBIN JAMES R Director | Other disposition · Non-qualified stock option | −7,500 | 202,500 | ||
| 2010-10-04 | TOBIN JAMES R Director | Other disposition · Non-qualified stock option | −12,500 | 215,000 | ||
| 2010-10-04 | TOBIN JAMES R Director | Other disposition · Non-qualified stock option | −12,500 | 227,500 | ||
| 2010-06-03 | Rubin Marc Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2010-02-02 | PASSERI DANIEL R CEO and Director | Grant or award · Qualified stock option (right to buy) | +47,714 | 47,714 | ||
| 2010-02-02 | Keegan Mitchell Vice-President | Grant or award · Qualified stock option (right to buy) | +25,283 | 25,283 | ||
| 2010-02-02 | Keegan Mitchell Vice-President | Grant or award · Non-qualified stock option (right to buy) | +34,717 | 34,717 | ||
| 2010-02-02 | GRAY MICHAEL COO and CFO | Grant or award · Qualified stock option (right to buy) | +39,063 | 39,063 | ||
| 2010-02-02 | GRAY MICHAEL COO and CFO | Grant or award · Non-qualified stock option (right to buy) | +85,937 | 85,937 | ||
| 2010-02-02 | NOEL MARK Vice-President | Grant or award · Qualified stock option (right to buy) | +37,368 | 37,368 | ||
| 2010-02-02 | NOEL MARK Vice-President | Grant or award · Non-qualified stock option (right to buy) | +22,632 | 22,632 | ||
| 2010-02-02 | Qian Changgeng VP, Research & Preclinical Dev | Grant or award · Qualified stock option (right to buy) | +39,063 | 39,063 | ||
| 2010-02-02 | Qian Changgeng VP, Research & Preclinical Dev | Grant or award · Non-qualified stock option (right to buy) | +85,937 | 85,937 | ||
| 2010-02-02 | MCNAB JAMES R Director | Grant or award · Non-qualified stock option (right to buy) | +85,000 | 85,000 | ||
| 2010-02-02 | TOBIN JAMES R Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 |
Page 24 of 29 · 564 trades